Does TOFACITINIB Cause Chromaturia? 110 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 110 reports of Chromaturia have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
110
Reports of Chromaturia with TOFACITINIB
0.1%
of all TOFACITINIB reports
1
Deaths
17
Hospitalizations
How Dangerous Is Chromaturia From TOFACITINIB?
Of the 110 reports, 1 (0.9%) resulted in death, 17 (15.5%) required hospitalization.
Is Chromaturia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 110 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Chromaturia?
ECULIZUMAB (669)
ATORVASTATIN (458)
RIVAROXABAN (334)
METRONIDAZOLE (299)
DIMETHYL (269)
ADALIMUMAB (256)
ROSUVASTATIN (230)
APIXABAN (215)
RIBAVIRIN (200)
OMEPRAZOLE (192)
Which TOFACITINIB Alternatives Have Lower Chromaturia Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN